Effect of Preoperative Tramadol and Naproxen Sodium on Post Operative Pain
NCT ID: NCT05982392
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
47 participants
INTERVENTIONAL
2023-03-01
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* Local anesthetic efficacy and .
* Postoperative pain. Participants will receive premedication treatments 60 minutes prior to the local anesthesia administration.
Researchers will compare Tramadol, Naproxen sodium and Placebo to evaluate their effects on Inferior alveolar nerve block efficacy and Postoperative pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Oral Analgesics on Post-op Pain
NCT07204379
Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block.
NCT05488925
The Effects of Three Oral Medications on Post-operative Pain Following Endodontic Treatment
NCT01178203
Comparison Of The Effect Of Final Rinse Of Tramadol and Dexamethasone on Post-Endodontic Pain in Teeth With SIP
NCT07036237
Effect of Preoperative Oral Tramadol on Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis
NCT04961268
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomization: The participants will be randomly divided into 3 groups by envelope method.
Group A will receive premedication of Oral tramadol 100mg, Group B will receive premedication of oral naproxen 550mg. Both medicines will be given 60 minutes prior to the local anesthesia administration. The third group, Group C, will be the control group and no active preoperative medication will be given to these participants. A placebo will be given to these participants. These medications will be given as a single intervention only.
Blinding: Clinician and participants both will be blind to the medicine given to the participants. Participants will be allowed to pick envelopes and a paramedical staff will be trained in giving medication to the participants.
Pain scores will be recorded by asking the participant to rate their pain on a scale ranging from 0 to 10 before medication and then after 15 minutes, 30 minutes and 60 minutes of administering the premedication. Pain score will also be recorded after 10 minutes of the administration of Inferior alveolar nerve block (IANBs) and buccal nerve block \& during deroofing process of chamber opening.
Two cartridges of Lidocaine 1.8 ml having a concentration of 1:100,000 of Epinephrine will be used for administration of regional anesthesia. Access opening will be performed under rubber dam isolation with a Mani number 245 bur in a high-speed hand piece with copious water irrigation. Sodium hypochlorite (5.25%) will be used as a standard root canal irrigation solution.Pulpectomy will be performed with Mani K-files (8-25) till respective working lengths of the teeth under study.
To assess the post-operative pain, a proforma and pain intensity scale will be provided to the participants for self recording at 6, 24, 48 and 72 hours after the procedure. The participants will return the proforma to an intern on 3rd day to be assessed by an intern supervised by the principal investigator.
(For this research, "The investigators will be offering As per need analgesic for breakthrough pain. Participants will be offered brufen 400mg as needed. The participants will be advised to mark breakthrough pain on VAS at the time of taking medicine).
The participants will also be monitored for the adverse effects of these medications (nausea, vomiting, dizziness, drowsiness) as a secondary outcome .at above-mentioned time-intervals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tramadol
Group A will receive premedication of Oral tramadol 100mg,
Tramadol
Tramadol 100mg will be given 60 minutes before start of procedure.
Naproxen Sodium
Group B will receive premedication of oral naproxen sodium 550mg.
Naproxen Sodium
Naproxen sodium 550mg will be given 60 minutes before start of procedure.
Placebo
Group C, will be the control group and no active preoperative medication will be given to these patients.
Placebo
Placebo will be given 60 minutes before start of procedure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tramadol
Tramadol 100mg will be given 60 minutes before start of procedure.
Naproxen Sodium
Naproxen sodium 550mg will be given 60 minutes before start of procedure.
Placebo
Placebo will be given 60 minutes before start of procedure.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis).
* Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS= 1-10).
* Mandibular permanent premolar and molars.
Exclusion Criteria
* Patients suffering from severe pain because of traumatic occlusion.
* Teeth with extensive damage, calcified canals, root resorption, and an open apex.
* Previously root canal treated teeth.
* Medically compromised patients (ASA-III and above)
* Those with special communication needs or who do not understand Urdu or English language.
* Pregnant and lactating women
* Individual patients who will be driving back alone
* Patients who are allergic to the prescribed medicines
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dow University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tayyaba Tahira
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tayyaba Tahira, BDS FCPS
Role: PRINCIPAL_INVESTIGATOR
Dow International Dental College, Dow University of Health Sciences
Farah Naz, BDS FCPS
Role: STUDY_DIRECTOR
Dow International Dental College, Dow University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dow International Dental College
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2889
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.